跳至主要内容
临床试验/KCT0000193
KCT0000193已完成未知

Efficacy and safety of metformin plus carnitine complex(Godex) compaired with metformin monotherapy in type 2 DM and impaired glucose tolerance patients with non-alcoholic fatty liver disease; A randomized, placebo controlled, double blind, parallel desinged phase 4 clinical trials.

Seoul National University Bundang Hospital0 个研究点目标入组 58 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
58

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
18(Year) 至 79(Year)(—)
性别
All

入选标准

  • 1) Age at least 18 years and under 80 years
  • 2) Subjects with non-alcoholic fatty liver disease; 35U/L = ALT = 250u/L
  • 3) 100mg/dL = fasting glucose = 300mg/dL or HbA1c > 6.5%
  • 4) Able and willing to provide informed consent

排除标准

  • 1) Subject with current viral hepatitis(HAV, HBV, HCV), alcoholic liver disease, and other liver disease
  • 2) Subject with allergy to study agent(s) or their formulations
  • 3) Current levodopa medication
  • 4) Pregnant or breastfeeding women
  • 5) Subject who participated in any clinical studies within 30 days prior to study entry and during study
  • 6) Subjects who were prescribed hypoglycemic agent including insulin within 30 days of screening or prior to randomization
  • 7) Inability or unwillingness to give informed consent or abide by the study protocol

研究者

相似试验